*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Nateglinide Impurity 6 is a <strong>process-related impurity</strong> generated during the synthesis of the antidiabetic drug Nateglinide. It typically arises from incomplete reactions or side pathways in the manufacturing process. The molecular formula is C<sub>15</sub>H<sub>21</sub>NO<sub>4</sub>, and its CAS registry number is <strong>197086-48-5</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical R&D:</strong> Used as reference standards for method validation and stability testing.</li>
<li><strong>Quality Control:</strong> Essential for identifying and quantifying trace impurities in bulk drug substances.</li>
<li><strong>Regulatory Compliance:</strong> Supports submission dossiers to agencies like the FDA and EMA regarding impurity profiles.</li>
</ul>
<h3>Precautions</h3>
<p>Store under <strong>inert atmosphere</strong> at controlled temperatures below 25°C. Handle with appropriate PPE to avoid skin contact. Strictly limit exposure in clinical settings as it lacks therapeutic value and may affect drug safety profiles.</p>